TD Waterhouse Canada’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
56,073
+14,920
| +36% | +$90.9K | ﹤0.01% | 727 |
|
|
2025
Q1 | $234K | Buy |
41,153
+15,751
| +62% | +$89.7K | ﹤0.01% | 761 |
|
|
2024
Q4 | $182K | Buy |
25,402
+1,515
| +6% | +$10.8K | ﹤0.01% | 819 |
|
|
2024
Q3 | $188K | Sell |
23,887
-299
| -1% | -$2.36K | ﹤0.01% | 784 |
|
|
2024
Q2 | $203K | Buy |
24,186
+8,929
| +59% | +$75K | ﹤0.01% | 765 |
|
|
2024
Q1 | $166K | Sell |
15,257
-1,153
| -7% | -$12.6K | ﹤0.01% | 804 |
|
|
2023
Q4 | $158K | Buy |
16,410
+15,010
| +1,072% | +$145K | ﹤0.01% | 723 |
|
|
2023
Q3 | $18.1K | Hold |
1,400
| – | – | ﹤0.01% | 1111 |
|
|
2023
Q2 | $23.6K | Buy |
1,400
+400
| +40% | +$6.74K | ﹤0.01% | 1095 |
|
|
2023
Q1 | $12.9K | Sell |
1,000
-270
| -21% | -$3.47K | ﹤0.01% | 1173 |
|
|
2022
Q4 | $19K | Hold |
1,270
| – | – | ﹤0.01% | 1105 |
|
|
2022
Q3 | $6.74K | Hold |
1,270
| – | – | ﹤0.01% | 1296 |
|
|
2022
Q2 | $12K | Buy |
1,270
+270
| +27% | +$2.56K | ﹤0.01% | 1212 |
|
|
2022
Q1 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 1307 |
|
|
2021
Q4 | $13.5K | Buy |
+1,000
| New | +$13.5K | ﹤0.01% | 1286 |
|